For patients with inoperable/locally advanced Stage IIIB NSCLC with driver mutations who have an excellent response to initial TKI treatment, do you ever re-visit more definitive options?

For patients who either could not initially tolerate chemoradiation or surgery (or where it was not feasible), how would you decide whether/when to incorporate these modalities into their treatment?